updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
zoeti clear leader global anim health industri
believ possess widest moat competitor
industri whole possess mani characterist
conduc moat zoeti global infrastructur give cost
advantag peer firm also set apart base
impress innov show broad product
portfolio includ number drug specif canin
anim health industri long larg ignor
busi buri within larger human health
compani longer mani attract characterist
includ cash-pay buyer fragment custom base
minim gener competit due fragment cash-pay
human health side firm tradit merci
payer govern payer larg managed-car firm
pharmaci benefit manag power forc gener
util squash price increas even extrem case forc
product purchas fragment group protein
produc veterinarian pet owner allow littl
bargain power highli concentr anim health firm
industri also benefit favor growth tailwind
allow zoeti increas revenu mid-single-digit
long-term growth rate product anim side rise
standard live emerg market lead wider
adopt meat-heavi diet drive greater demand livestock
product companion side zoeti benefit pet owner
increasingli strong relationship pet member
famili drastic increas willing pay
expens treatment zoeti like grow rate rel
close industri abl maintain
above-averag margin due scale especi emerg
market zoeti scale allow use salesforc
smaller competitor often forc reli expens
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
zoeti sell anti-infect vaccin parasiticid diagnost
health product anim firm earn roughli half total revenu
product anim cattl pig poultri companion
anim dog hors cat product make half firm
largest market share industri previous anim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
hold steadi fair valu estim per
share make near-term downward adjust
accommod impact revis
anticip damp full-year top-lin growth
previous make materi differ
valuat project product companion
anim growth soften respect
oper profit margin declin basi point
long-term expect remain favor
stronger growth stem zoeti larger presenc
companion anim diagnost improv profit
thank new product estim companion anim
segment return low-double-digit growth
drive total revenu growth next
five year project growth earn
interest long term
ration
remain posit profit gain follow
product portfolio
brand companion anim drug
busi -- gain come fruition
project adjust oper margin reach
basi point next five year
expect improv split nearli evenli
gain gross margin thank slim
product portfolio product anim consolid
manufactur site half driven
effici deploy sale field support howev
benefit firm effici program
slightli off-set lower-margin emerg market make
grow portion zoeti sale well greater
 invest maintain brand drug innov
whole project factor translat
adjust averag annual earn growth
base averag volatil cash flow divers
product portfolio anim health market rate
zoeti uncertainti medium
base case forecast long-term tax rate
long-term oper margin firm
abl boost sale product anim product
leverag greater price power companion anim
portfolio project adjust oper margin near
fair valu estim would per share
firm see flat growth product anim
next five year due greater restrict antibiot use
anim improv oper margin basi
point penetr emerg market pressur
profit fair valu estim would fall per
zoeti enjoy wide econom moat thank intang
asset cost advantag although patent
essenti maintain product anim health
industri least firm revenu come
product protect patent allow zoeti charg
premium price insul competit firm
strong brand name anoth advantag competitor
custom use drug potenti million
dollar worth livestock pet love like
famili member will pay premium buy
firm trust
zoeti also enjoy anoth intang asset comparison
competitor embed larger human
pharmaceut firm zoeti free develop therapeut
base unmet anim need competitor applic
therapeut origin design human anim
market also mean firm unlik invest
animal-specif therapi sizabl opportun
relat unmet anim need zoeti pioneer
includ cytopoint canin allergi
scale also provid zoeti key advantag
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
product develop expect industri
face materi chang competit landscap
highli fragment custom base salesforc
distribut relationship extrem import
launch new product simpl get one
larg payer managed-car organ medicar
govern board compani need individu
deal veterinarian meat produc zoeti broad
portfolio support salesforc allow firm
bypass distributor
barrier entri signific capit time
although nearli expens time-consum
human health still challeng bring new
anim health product market given small market
size rel modest sale potenti product
reward often justifi new competitor pursu
clinic trial bring product market
believ zoeti stabl moat trend compani
compet matur industri experienc
signific chang even spin-out eli lilli
anim health unit elanco consid heavi
concentr among top firm revolutionari
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ogrow interest probiot antibacteri peptid
immun modul altern antibiot
offer mani target innov
ostrict regul restrict antibiot use
ocompanion anim increasingli view famili
spend pet healthcar
olower-margin emerging-market sale make
increas portion compani sale creat
headwind zoeti margin
osinc anim health industri lack larg payer
like medicar single-pay govern larg
oemerging-market custom may price-
sensit open use gener product
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
zoeti enjoy solid financi flexibl even leverag
tick financ purchas pharmaq
abbott anim health busi long-term debt
roughli billion end zoeti alreadi
brought debt/ebitda time time
four year expect leverag land low end
target rang time end year
remain comfort interest coverag around time
base averag volatil cash flow divers
product portfolio anim health market rate
zoeti uncertainti medium thank grow consum
medic concern use antibiot
food suppli food drug administr
meat product industri final begun react
industri alreadi roll new standard call
voluntari monitor use anim howev
grassroot pressur continu build risk
fda could eventu issu restrict guidelin
product anim segment offer rel
steadi growth remain expos macroeconom trend
emerg market adopt higher-protein diet
like fuel underli demand zoeti product
addit product anim busi vulner
unpredict diseas outbreak lead
large-scal cull herd companion anim market
price elast pet healthcar clear pet owner
continu spend pet point
rise price may owner will bear
segment market vulner
macroeconom downturn caus consum pull
back spend
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
give firm standard stewardship rate kristin peck
recent elev ceo role follow former
ceo juan ramon alaix step similar ramon
alaix peck also come tenur
zoeti sinc spin bring substanti
experi time lead strategi
licens arrang follow work zoeti
corpor strategi busi develop suppli chain
manag anticip major deviat
earlier strategi increas zoeti scale breadth
seri acquisit allow firm
enter adjac market includ aquacultur
monoclon antibodi pet
current cfo glenn david prove highli
compet role david longtim veteran
deep experi healthcar well acquisit
integr new busi expect see
dramat departur firm current strategi
serial acquisit though leverag settl lower
expect former cfo paul herendeen
repres date owner name posit common share held report holder issuer
new york mellon corp
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
zoeti strengthen presenc diagnost rais
acquir abaxi last year zoeti enlarg
footprint anim diagnost recent purchas
refer lab substanti boost fair valu
estim per share driven primarili
expect addit expans
diagnost portfolio support robust growth
longer term consid zoeti initi foray
diagnost surpris see firm
assert build presenc market weve
seen competitor vca part
mar companion anim diagnost market
highli attract think addit refer lab
offer strong complement benchtop analyz
legaci abaxi strateg perspect like
ad companion anim diagnost mix
therapeut zoeti offer maxim effici
veterinarian call point posit zoeti
import vendor companion anim
continu think zoetisand larger anim health
industri matteri overvalu last
sever year weve seen high level activ
mar buy vca acquir buffalo
impend purchas petfirst healthcar zoeti
made serial acquisit get aquacultur pain
manag diagnost rais question
price zoeti pay purchas
often privat held although zoeti hasnt disclos
price paid phoenix lab strongli suspect may
paid premium recent septemb phoenix
talk rival purchas
veterinari trade journal suggest zoeti beaten idexx
million bid million offer
differ million peanut zoeti gener
price leav us attent price futur purchas
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
